Kamil Musílek

A Resurrection of 7-MEOTA: A Comparison with Tacrine

Ondřej Soukup, Daniel Jun, Jana Žďárová Karasová et al. · Current Alzheimer Research · 2013 · 102 citations

Medicine, Pharmacokinetics, Pharmacology +17

Design of a Potent Reactivator of Tabun-Inhibited AcetylcholinesteraseSynthesis and Evaluation of (<i>E</i>)-1-(4-Carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene Dibromide (K203)

Kamil Musílek, Daniel Jun, Frank J. Gunn‐Moore et al. · Journal of Medicinal Chemistry · 2007 · 101 citations

Pharmacy, Pharmacology, Toxicology +16

7-MEOTA–donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies

Jan Korábečný, Rafael Doležal, Pavla Cabelova et al. · European Journal of Medicinal Chemistry · 2014 · 81 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice

Jana Žďárová Karasová, Kamil Musílek, Kamil Kuča · Toxicology · 2007 · 76 citations

Life Sciences, Medicinal Chemistry, Pharmacology +10

Progress in Synthesis of New Acetylcholinesterase Reactivators During the Period 1990-2004

Kamil Musílek, Kamil Kuča, Daniel Jun et al. · Current Organic Chemistry · 2006 · 75 citations

Medicine, Chemistry, Pharmacology +17